financetom
Business
financetom
/
Business
/
Park National Q1 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Park National Q1 Earnings, Revenue Rise
Apr 19, 2024 2:30 PM

04:50 PM EDT, 04/19/2024 (MT Newswires) -- Park National ( PRK ) reported Q1 earnings Friday of $2.17 per diluted share, up from $2.07 a year earlier.

Three analysts polled by Capital IQ expected $1.83.

Revenue for the quarter ended March 31, expressed as the sum of net interest income and other income, was $121.8 million, up from $116.6 million a year earlier.

Two analysts surveyed by Capital IQ expected $117.4 million.

Park National ( PRK ) said its board maintained its quarterly dividend at $1.06 per share, payable on June 10 to shareholders of record on May 17.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Kandi Technologies Says Unit Gets First 'Major Order' From Contemporary Amperex
Kandi Technologies Says Unit Gets First 'Major Order' From Contemporary Amperex
Aug 18, 2025
07:47 AM EDT, 08/18/2025 (MT Newswires) -- Kandi Technologies Group ( KNDI ) said Monday its China Battery Exchange (Zhejiang) Technology unit received its first major order for heavy-truck battery swap station equipment from Contemporary Amperex Technology. China Battery Exchange will deliver core station structures, advanced robotic arm systems, and precision temperature-controlled battery compartments designed for heavy-duty truck applications, the...
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
FibroGen Says China Unit Sale to AstraZeneca Receives Regulatory Approval
Aug 18, 2025
07:44 AM EDT, 08/18/2025 (MT Newswires) -- FibroGen ( FGEN ) said Monday the China State Administration for Market Regulation has approved the sale of its subsidiary in China to AstraZeneca ( AZN ) unit AstraZeneca Treasury. FibroGen ( FGEN ) said the transaction remains on track to close in Q3, pending other contractual conditions and deliverables. FibroGen ( FGEN...
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Labcorp Holdings Launches FDA-Cleared Blood Test Lumipulse to Help Diagnose Alzheimer's Disease
Aug 18, 2025
07:39 AM EDT, 08/18/2025 (MT Newswires) -- Labcorp Holdings ( LH ) said Monday that Lumipulse, the first blood test cleared by the US Food and Drug Administration to help diagnose Alzheimer's disease, is now available nationwide. The test offers results that are comparable to existing methods, but is less invasive and more affordable and accessible, the company said. Lumipulse...
International Petroleum Released Results of Latest Normal Course Issuer Bid
International Petroleum Released Results of Latest Normal Course Issuer Bid
Aug 18, 2025
07:47 AM EDT, 08/18/2025 (MT Newswires) -- International Petroleum ( IPCFF ) earlier on Monday announced that it repurchased a total of 144,952 common shares during the period of August 11 to 15, 2025 under its normal course issuer bid, share repurchase program (NCIB). During the period, IPC repurchased a total of 88,052 IPC common shares on Nasdaq Stockholm. During...
Copyright 2023-2026 - www.financetom.com All Rights Reserved